|
|
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 7 D) G) b* s# r8 T4 F
% H6 X8 m1 D, e7 _* O& _今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
! Q/ s- T9 @& L$ A) S+ v7 X; v! P( i% q. B' P: z; V
头颈肿瘤BU入选ASCO 2025的研究
: P; ~( k+ j+ e1 C5 u/ V1 tHot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
J/ L0 u4 X, H* n肿瘤内科-头颈肿瘤科姜愚团队
8 y i6 i3 O, w' ^
/ u3 J; A1 W' q% u+ A$ |, k' f6 b y1 lNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.7 p+ L0 M8 T5 [2 }! U+ j
肿瘤内科-头颈肿瘤科刘磊团队
+ J/ |( g; M; f7 c# N9 p% J0 F
" O( D( J `# @) [0 H9 gA phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
& l$ E% }' p: x肿瘤内科-头颈肿瘤科刘磊团队" A( t/ x1 q2 Y/ H$ g: R, y
" R5 C, t3 H, [
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
p8 m- a* s' Y$ ~" w6 t1 h4 W2 H肿瘤内科-头颈肿瘤科刘磊团队: \7 X# F6 i1 S4 G+ t" b1 b# e( J
# [3 _2 { \# `+ e5 Yribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.9 F0 T, C( W. a9 U
肿瘤内科-头颈肿瘤科姜愚团队( U4 W0 D. l+ z K9 m' h8 y
|
|
[复制链接]
楼主
发表于 